Rolph Timothy bought AKRO

November 25, 2025 · Form 4 insider transaction

Rolph Timothy bought 43,064 shares of Akero Therapeutics, Inc. at $6.36 per share, a transaction worth $274.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
43,064
Price
$6.36
Total value
$274.1K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 25, 2025
Filing dateNovember 28, 2025
Shares owned after176,062
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR